These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 1902054)

  • 1. Comparison of effects of thrombolytic therapy on left ventricular function in patients over with those under 60 years of age.
    White H; Cross D; Scott M; Norris R
    Am J Cardiol; 1991 May; 67(11):913-8. PubMed ID: 1902054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A difference between front-loaded streptokinase and standard-dose recombinant tissue-type plasminogen activator in preserving left ventricular function after acute myocardial infarction (the Central Illinois Thrombolytic Therapy Study).
    Taylor GJ; Moses HW; Koester D; Colliver JA; Katholi RE; Dove JT; Woodruff RC; Mikell FL; Becker LC; Sheehan FH
    Am J Cardiol; 1993 Nov; 72(14):1010-4. PubMed ID: 8213579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of intravenous streptokinase as compared with that of tissue plasminogen activator on left ventricular function after first myocardial infarction.
    White HD; Rivers JT; Maslowski AH; Ormiston JA; Takayama M; Hart HH; Sharpe DN; Whitlock RM; Norris RM
    N Engl J Med; 1989 Mar; 320(13):817-21. PubMed ID: 2494454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased left ventricular dysfunction in elderly patients despite successful thrombolysis: the GUSTO-I angiographic experience.
    Lesnefsky EJ; Lundergan CF; Hodgson JM; Nair R; Reiner JS; Greenhouse SW; Califf RM; Ross AM
    J Am Coll Cardiol; 1996 Aug; 28(2):331-7. PubMed ID: 8800106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative radionuclide assessment of regional ventricular function after thrombolytic therapy for acute myocardial infarction: results of phase I Thrombolysis in Myocardial Infarction (TIMI) trial.
    Wackers FJ; Terrin ML; Kayden DS; Knatterud G; Forman S; Braunwald E; Zaret BL
    J Am Coll Cardiol; 1989 Apr; 13(5):998-1005. PubMed ID: 2494246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous streptokinase in acute myocardial infarction (I.S.A.M.) trial: serial evaluation of left ventricular function up to 3 years after infarction estimated by radionuclide ventriculography. I.S.A.M. Study Group.
    Voth E; Tebbe U; Schicha H; Neuhaus KL; Schröder R
    J Am Coll Cardiol; 1991 Dec; 18(7):1610-6. PubMed ID: 1960304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction.
    GUSTO Angiographic Investigators
    N Engl J Med; 1993 Nov; 329(22):1615-22. PubMed ID: 8232430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the effects of streptokinase and tissue plasminogen activator on regional wall motion after first myocardial infarction: analysis by the centerline method with correction for area at risk.
    Cross DB; Ashton NG; Norris RM; White HD
    J Am Coll Cardiol; 1991 Apr; 17(5):1039-46. PubMed ID: 1901072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rescue thrombolysis: alteplase as adjuvant treatment after streptokinase in acute myocardial infarction.
    Mounsey JP; Skinner JS; Hawkins T; MacDermott AF; Furniss SS; Adams PC; Kesteven PJ; Reid DS
    Br Heart J; 1995 Oct; 74(4):348-53. PubMed ID: 7488444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The influence of thrombolytic therapy on selected parameters of left ventricular function in acute myocardial infarction].
    Wrzesiński K; Kopaczewski J; Wlazłowski R; Gawor Z; Goch JH
    Pol Arch Med Wewn; 1999 Jun; 101(6):495-502. PubMed ID: 10754735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New developments in thrombolytic therapy.
    Collen D; Gold HK
    Adv Exp Med Biol; 1990; 281():333-54. PubMed ID: 2129372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of late administration of tissue-type plasminogen activator on left ventricular remodeling and function after myocardial infarction.
    Bonaduce D; Petretta M; Villari B; Breglio R; Conforti G; Montemurro MV; Lanzillo T; Morgano G
    J Am Coll Cardiol; 1990 Dec; 16(7):1561-8. PubMed ID: 2123907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of late coronary thrombolysis (recombinant tissue-type plasminogen activator) in preserving left ventricular function in acute myocardial infarction.
    Villari B; Piscione F; Bonaduce D; Golino P; Lanzillo T; Condorelli M; Chiariello M
    Am J Cardiol; 1990 Dec; 66(19):1281-6. PubMed ID: 2123072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left ventricular function as an end-point of thrombolytic therapy.
    Norris RM; White HD
    Eur Heart J; 1990 Aug; 11 Suppl F():5-9. PubMed ID: 2121490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group.
    Grines CL; Browne KF; Marco J; Rothbaum D; Stone GW; O'Keefe J; Overlie P; Donohue B; Chelliah N; Timmis GC
    N Engl J Med; 1993 Mar; 328(10):673-9. PubMed ID: 8433725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and biochemical predictors affect the choice and the short-term outcomes of different thrombolytic agents in acute myocardial infarction.
    El-Menyar AA; Altamimi OM; Gomaa MM; Dabdoob W; Abbas AA; Abdel Rahman MO; Bener A; Albinali HA
    Coron Artery Dis; 2006 Aug; 17(5):431-7. PubMed ID: 16845251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of intravenous thrombolytic therapy on left ventricular function: a report on tissue-type plasminogen activator and streptokinase from the Thrombolysis in Myocardial Infarction (TIMI Phase I) trial.
    Sheehan FH; Braunwald E; Canner P; Dodge HT; Gore J; Van Natta P; Passamani ER; Williams DO; Zaret B
    Circulation; 1987 Apr; 75(4):817-29. PubMed ID: 3103950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators.
    Weaver WD; White HD; Wilcox RG; Aylward PE; Morris D; Guerci A; Ohman EM; Barbash GI; Betriu A; Sadowski Z; Topol EJ; Califf RM
    JAMA; 1996 Mar; 275(10):777-82. PubMed ID: 8598594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left ventricular function after late thrombolysis with alteplase in myocardial infarction.
    Gil VM; Ventosa A; Antunes AF; Morais J; Seabra-Gomes R
    Rev Port Cardiol; 1996 May; 15(5):413-20, 366. PubMed ID: 8763515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The state of lipid peroxidation and antioxidants following thrombolytic therapy with rt-PA and streptokinase in acute myocardial infarction.
    Ozmen D; Boydak B; Mutaf I; Zoghi M; Kumanlioğlu K; Güner I; Bayindir O
    Jpn Heart J; 1999 May; 40(3):267-73. PubMed ID: 10506849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.